Ari Bronsoler
YOU?
Author Swipe
View article: Replication Package for: Private Sector Provision as an Escape Valve: The Mexico Diabetes Experiment
Replication Package for: Private Sector Provision as an Escape Valve: The Mexico Diabetes Experiment Open
Bronsoler, A., Gruber, J., & Seira, E. (2023). Private Sector Provision as an “Escape Valve”: The Mexico Diabetes Experiment . Replication package for tables and figures. Includes publically available data and de-identified experimental da…
View article: Replication Package for: Private Sector Provision as an Escape Valve: The Mexico Diabetes Experiment
Replication Package for: Private Sector Provision as an Escape Valve: The Mexico Diabetes Experiment Open
Bronsoler, A., Gruber, J., & Seira, E. (2023). Private Sector Provision as an “Escape Valve”: The Mexico Diabetes Experiment . Replication package for tables and figures. Includes publically available data and de-identified experimental da…
View article: The Impact of Health Information and Communication Technology on Clinical Quality, Productivity, and Workers
The Impact of Health Information and Communication Technology on Clinical Quality, Productivity, and Workers Open
The adoption of health information and communication technology (HICT) has surged over the past two decades. We survey the medical and economic literature on HICT adoption and its impact on clinical outcomes, productivity, and the health c…
View article: The Impact of Healthcare IT on Clinical Quality, Productivity and Workers
The Impact of Healthcare IT on Clinical Quality, Productivity and Workers Open
Adoption of health information and communication technologies ("HICT") has surged over the past two decades.We survey the medical and economic literature on HICT adoption and its impact on clinical outcomes, productivity and labor.We find …
View article: The Impact of a Private Supplement to Public Health Care: The Mexico Diabetes Experiment
The Impact of a Private Supplement to Public Health Care: The Mexico Diabetes Experiment Open
There are ongoing debates around the world over the value of private supplements to public health insurance systems.We investigate this issue in the context of one of the world's deadliest diseases, diabetes, and one of the countries with …